"In 1981, Dr. James H. Johnston, III, Billy W. Long, and Dr. James Q. Sones saw a need for gastrointestinal care in the Jackson metro area. They organized GI Associates and in 1987. The Gastrointestinal Associates Endoscopy Center, an outpatient procedure facility was built in 2001 to provide patients a state of the art facility with the latest technology combined with the highest level of service. The practice has expanded to include additional board certified Gastroenterologists and other specialized staff plus various outpatient procedures and clinical trials of new treatments."

During the past decade, Gastrointestinal Associates, PA conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 20 clinical trials were completed, i.e. on average, 90.9% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 13 clinical trials were completed. i.e. 162.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Gastrointestinal Associates, PA" #1 sponsor was "Bausch Health Americas, Inc." with 4 trials, followed by "Braintree Laboratories" with 4 trials sponsored, "Celgene" with 3 trials sponsored, "Forest Laboratories" with 3 trials sponsored and "Gilead Sciences" with 3 trials sponsored. Other sponsors include 24 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Gastrointestinal Associates, PA" #1 collaborator was "Ironwood Pharmaceuticals, Inc." with 2 trials as a collaborator, "Allergan Sales, LLC" with 1 trials as a collaborator, "Parexel" with 1 trials as a collaborator, "RTI Health Solutions" with 1 trials as a collaborator and "Sucampo AG" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Gastrointestinal Associates, PA" are "Hepatitis C, Chronic" (5 trials), "Ulcerative Colitis" (5 trials), "Colonoscopy" (4 trials), "Eosinophilic Esophagitis" (3 trials) and "Inflammatory Bowel Disease" (3 trials). Many other conditions were trialed in "Gastrointestinal Associates, PA" in a lesser frequency.

Most popular intervention types in "Gastrointestinal Associates, PA" are "Drug" (43 trials), "Biological" (3 trials), "Device" (2 trials), "Diagnostic Test" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (20 trials), "Lubiprostone" (3 trials), "AQUAVAN® (fospropofol disodium) Injection" (2 trials), "CC-93538" (2 trials) and "GS-9451" (2 trials). Other intervention names were less common.

The vast majority of trials in "Gastrointestinal Associates, PA" are 44 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Gastrointestinal Associates, PA". 1 are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 35 completed trials in Gastrointestinal Associates, PA, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Gastrointestinal Associates, PA, 0 "Phase 1" clinical trials were conducted, 21 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".